Leadership Overview
ProPharma Group has 7 executives leading key functions including financial strategy, information technology, human resources, life science consulting, pharmacovigilance, corporate operations, and clinical research solutions.
Focused on delivering regulatory and compliance excellence, ProPharma Group empowers the medical industry through specialized consulting and rigorous safety standards.
Focused on delivering regulatory and compliance excellence, ProPharma Group empowers the medical industry through specialized consulting and rigorous safety standards.
Leadership Roles at ProPharma Group
Jon Otterberg - Chief Financial Officer
Jon Otterberg, the Chief Financial Officer at ProPharma Group, directs all global fiscal operations and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures alignment with long-term growth objectives in the regulatory compliance sector. This leadership role involves managing complex budgetary frameworks and optimizing resource distribution across North American and international markets. By implementing robust financial controls, Jon Otterberg directly impacts the scalability of the company's service offerings. Otterberg maintains close collaboration with the Board to secure sustainable revenue streams while mitigating fiscal risks. Through precise financial planning, the Chief Financial Officer supports the expansion of the firm's footprint in the medical industry. Ultimately, Otterberg drives the economic stability required to maintain the company's position as a premier provider of compliance solutions for global life science clients.
James Kolbet - President Life Science Consulting
James Kolbet, the President Life Science Consulting at ProPharma Group, directs the strategic advisory services provided to medical industry partners. Overseeing the consulting division, the President Life Science Consulting ensures that clients receive actionable regulatory guidance. This leadership role involves managing complex client engagements and expanding the firm's influence in the life science sector. By optimizing service delivery, James Kolbet directly impacts the success of client compliance programs. Kolbet collaborates with other executive leaders to integrate consulting insights into broader company offerings. Through the development of specialized advisory frameworks, the President Life Science Consulting addresses the unique challenges faced by medical organizations. Ultimately, Kolbet drives the growth of the consulting practice by maintaining a focus on high-value regulatory solutions that ensure client success in competitive global markets.
Laura Hopper - President, Pharmacovigilance
Laura Hopper, the President, Pharmacovigilance at ProPharma Group, directs the safety monitoring and risk management operations for medical products. Overseeing the pharmacovigilance department, the President, Pharmacovigilance ensures that all regulatory reporting meets global safety standards. This leadership role involves managing large-scale safety databases and coordinating with health authorities to protect patient welfare. By streamlining safety assessment processes, Laura Hopper directly impacts the reliability of the company's compliance solutions. Hopper collaborates with clinical research teams to ensure seamless data integration across the product lifecycle. Through the implementation of rigorous safety protocols, the President, Pharmacovigilance maintains the integrity of the firm's regulatory services. Ultimately, Hopper drives the operational excellence required to support the medical industry in navigating complex safety requirements while ensuring that all pharmacovigilance activities remain compliant with international regulations.
Jason DeGoes - President
Jason DeGoes, the President at ProPharma Group, directs the overall corporate strategy and operational execution of the firm. Overseeing the integration of various business units, the President ensures that the company maintains its focus on regulatory and compliance excellence. This leadership role involves coordinating between departments to drive efficiency and market expansion. By aligning corporate goals with client needs, Jason DeGoes directly impacts the firm's competitive position in the medical industry. DeGoes collaborates with the executive team to refine the company's service model and enhance value for stakeholders. Through the management of cross-functional initiatives, the President fosters a unified approach to delivering high-quality solutions. Ultimately, DeGoes drives the strategic vision that allows the organization to navigate the complexities of the medical sector while maintaining a commitment to superior regulatory outcomes.
Daniel Ryan - President, Clinical Research Solutions
Daniel Ryan, the President, Clinical Research Solutions at ProPharma Group, directs the execution of clinical trials and research programs. Overseeing the clinical research division, the President, Clinical Research Solutions ensures that all studies adhere to strict regulatory and ethical guidelines. This leadership role involves managing complex research projects and coordinating with global medical partners to advance product development. By optimizing trial management processes, Daniel Ryan directly impacts the speed and accuracy of clinical data collection. Ryan collaborates with the pharmacovigilance and consulting teams to provide a comprehensive approach to medical compliance. Through the application of advanced research methodologies, the President, Clinical Research Solutions supports the firm's mission to improve patient outcomes. Ultimately, Ryan drives the success of clinical research initiatives by ensuring that all operations meet the highest standards of quality and regulatory compliance.
Kirk Wroblewski - Chief Information Officer
Kirk Wroblewski, the Chief Information Officer at ProPharma Group, architects the digital infrastructure necessary for secure regulatory data management. Overseeing the enterprise technology stack, the Chief Information Officer ensures that all compliance platforms meet stringent industry security standards. This leadership role involves integrating advanced analytics into the company's service delivery model to enhance client outcomes. By modernizing internal systems, Kirk Wroblewski directly impacts the efficiency of global operations. Wroblewski collaborates with executive leadership to implement scalable cloud solutions that support the firm's rapid growth. Through the deployment of cutting-edge software, the Chief Information Officer protects sensitive medical data across all regional operations. Ultimately, Wroblewski secures the technological foundation that allows the organization to provide high-quality regulatory and compliance solutions to the medical industry with unmatched precision and reliability.
Rachel Bias - Chief Human Resources Officer
Rachel Bias, the Chief Human Resources Officer at ProPharma Group, directs talent acquisition and organizational development strategies. Overseeing the human capital lifecycle, the Chief Human Resources Officer ensures that the firm attracts top-tier experts in regulatory and compliance fields. This leadership role involves fostering a culture of excellence that supports the company's mission within the medical industry. By implementing comprehensive training programs, Rachel Bias directly impacts employee retention and operational performance. Bias collaborates with the executive team to align workforce capabilities with the evolving needs of global life science clients. Through strategic talent management, the Chief Human Resources Officer builds the internal expertise required to maintain high service standards. Ultimately, Bias drives the organizational growth necessary to sustain the company's market leadership while ensuring that all personnel remain focused on delivering superior regulatory outcomes.
Explore Leadership Teams in Business Services
Teneo Teneo Holdings LLC is a global advisory and consulting firm that provides strategic counsel and business solutions to chief executive officers, boards of directors, senior executives, financial institutions, investors, and government organizations. The company specializes in helping leadership teams address complex business challenges, manage corporate transformations, navigate stakeholder expectations, and respond effectively to rapidly changing market conditions. Through an integrated advisory model, Teneo combines expertise from multiple disciplines to help organizations make informed decisions and achieve long-term strategic objectives. The firm was established with the vision of creating a modern advisory platform capable of addressing the increasingly interconnected issues faced by business leaders. Traditional consulting models often separate communications, financial advisory, restructuring, governance, public affairs, and strategic planning into independent disciplines. Teneo's approach seeks to integrate these capabilities within a single organization, allowing clients to receive coordinated advice across multiple areas of business management and corporate leadership.
Company Leadership PK
CF
DC
Moody's Corporation operates as an integrated risk assessment firm worldwide. It operates in two segments, Moody's Analytics and Moody's Investors Services. The Moody's Analytics segment develops a range of products and services that support the risk management activities of institutional participants in financial markets. It also offers credit research, credit models and analytics, economics data and models, and structured finance solutions; data sets on companies and securities; and SaaS solutions supporting banking, insurance, and know your customer workflows. The Moody's Investors Service segment publishes credit ratings and provides assessment services on various debt obligations, programs and facilities, and entities that issue such obligations, such as various corporate, financial institution, and governmental obligations, as well as structured finance securities. Moody's Corporation was founded in 1900 and is headquartered in New York, New York.
Company Leadership
LN
NM
AT
Xanadu Realty is a leading business transformation firm specializing in accelerating growth for clients in the real estate sector. They offer tailored solutions that leverage technology, data analytics, and innovative marketing strategies to create consumer-centric brands and drive high-performance results. Their expertise spans various asset classes, including residential, office, and retail properties across major cities in India. With a focus on institutional excellence and a commitment to nurturing talent, Xanadu Realty aims to inspire momentum and deliver sustainable success for its clients.
Company Leadership VC
HT
Headquartered in Singapore, NMG Group provides strategy, insights consulting, actuarial, marketing and research to multinational and domestic financial institutions.
Company Leadership MP
BN
BS
AV
Frequently Asked Questions Regarding ProPharma Group Top Executives and Leadership Team
